MANHATTAN ASSOCIATES INC (MANH) Fundamental Analysis & Valuation

NASDAQ:MANH • US5627501092

Current stock price

137.32 USD
-2.49 (-1.78%)
At close:
137.32 USD
0 (0%)
After Hours:

This MANH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. MANH Profitability Analysis

1.1 Basic Checks

  • In the past year MANH was profitable.
  • In the past year MANH had a positive cash flow from operations.
  • MANH had positive earnings in each of the past 5 years.
  • MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • MANH has a Return On Assets of 26.20%. This is amongst the best in the industry. MANH outperforms 98.56% of its industry peers.
  • With an excellent Return On Equity value of 69.88%, MANH belongs to the best of the industry, outperforming 97.84% of the companies in the same industry.
  • The Return On Invested Capital of MANH (58.53%) is better than 98.92% of its industry peers.
  • MANH had an Average Return On Invested Capital over the past 3 years of 56.95%. This is significantly above the industry average of 10.78%.
  • The 3 year average ROIC (56.95%) for MANH is below the current ROIC(58.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROIC 58.53%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • MANH's Profit Margin of 20.34% is amongst the best of the industry. MANH outperforms 87.41% of its industry peers.
  • MANH's Profit Margin has improved in the last couple of years.
  • MANH's Operating Margin of 26.15% is amongst the best of the industry. MANH outperforms 91.37% of its industry peers.
  • In the last couple of years the Operating Margin of MANH has grown nicely.
  • MANH has a worse Gross Margin (56.32%) than 64.03% of its industry peers.
  • MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. MANH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MANH is creating value.
  • Compared to 1 year ago, MANH has less shares outstanding
  • MANH has less shares outstanding than it did 5 years ago.
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 12.56 indicates that MANH is not in any danger for bankruptcy at the moment.
  • MANH's Altman-Z score of 12.56 is amongst the best of the industry. MANH outperforms 94.60% of its industry peers.
  • There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.56
ROIC/WACC5.36
WACC10.92%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • MANH has a Current Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.28, MANH is doing worse than 61.51% of the companies in the same industry.
  • MANH has a Quick Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • MANH has a worse Quick ratio (1.28) than 60.43% of its industry peers.
  • The current and quick ratio evaluation for MANH is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MANH Growth Analysis

3.1 Past

  • MANH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.19%.
  • The Earnings Per Share has been growing by 23.57% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 3.75% in the past year.
  • The Revenue has been growing by 13.02% on average over the past years. This is quite good.
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%

3.2 Future

  • MANH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.98% yearly.
  • MANH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.85% yearly.
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.02%
Revenue Next 5Y8.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. MANH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 27.08, the valuation of MANH can be described as expensive.
  • MANH's Price/Earnings ratio is a bit cheaper when compared to the industry. MANH is cheaper than 60.43% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, MANH is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 25.82, the valuation of MANH can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MANH.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. MANH is around the same levels.
Industry RankSector Rank
PE 27.08
Fwd PE 25.82
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MANH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MANH is cheaper than 67.63% of the companies in the same industry.
  • MANH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MANH is cheaper than 69.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.97
EV/EBITDA 27.3
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of MANH may justify a higher PE ratio.
PEG (NY)5.51
PEG (5Y)1.15
EPS Next 2Y8.76%
EPS Next 3Y9.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MANH Dividend Analysis

5.1 Amount

  • No dividends for MANH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANH Fundamentals: All Metrics, Ratios and Statistics

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (3/20/2026, 8:06:51 PM)

After market: 137.32 0 (0%)

137.32

-2.49 (-1.78%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-27
Earnings (Next)04-20
Inst Owners105.66%
Inst Owner Change-2.41%
Ins Owners1.18%
Ins Owner Change-1.47%
Market Cap8.22B
Revenue(TTM)1.08B
Net Income(TTM)219.95M
Analysts83.16
Price Target217.19 (58.16%)
Short Float %4.25%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.54%
Min EPS beat(2)5.72%
Max EPS beat(2)13.36%
EPS beat(4)4
Avg EPS beat(4)11.67%
Min EPS beat(4)5.72%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)14.56%
EPS beat(12)12
Avg EPS beat(12)18.24%
EPS beat(16)16
Avg EPS beat(16)21.82%
Revenue beat(2)0
Avg Revenue beat(2)-0.34%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)0.46%
Revenue beat(12)8
Avg Revenue beat(12)1.99%
Revenue beat(16)12
Avg Revenue beat(16)2.69%
PT rev (1m)-2.09%
PT rev (3m)-5.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 27.08
Fwd PE 25.82
P/S 7.6
P/FCF 21.97
P/OCF 21.1
P/B 26.11
P/tB 32.55
EV/EBITDA 27.3
EPS(TTM)5.07
EY3.69%
EPS(NY)5.32
Fwd EY3.87%
FCF(TTM)6.25
FCFY4.55%
OCF(TTM)6.51
OCFY4.74%
SpS18.07
BVpS5.26
TBVpS4.22
PEG (NY)5.51
PEG (5Y)1.15
Graham Number24.49
Profitability
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROCE 73.73%
ROIC 58.53%
ROICexc 410.13%
ROICexgc N/A
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
FCFM 34.59%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
ROICexc(3y)364.11%
ROICexc(5y)380.76%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)71.74%
ROCE(5y)64.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-0.52%
ROICexc growth 5Y23.6%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 244.69%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 134.74%
Profit Quality 170.05%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 12.56
F-Score7
WACC10.92%
ROIC/WACC5.36
Cap/Depr(3y)154.87%
Cap/Depr(5y)122.75%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.85%
Profit Quality(3y)145.98%
Profit Quality(5y)147.21%
High Growth Momentum
Growth
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.02%
Revenue Next 5Y8.85%
EBIT growth 1Y8.08%
EBIT growth 3Y22.8%
EBIT growth 5Y19.9%
EBIT Next Year8.14%
EBIT Next 3Y9.69%
EBIT Next 5Y13.03%
FCF growth 1Y30.62%
FCF growth 3Y29.3%
FCF growth 5Y22.03%
OCF growth 1Y32.02%
OCF growth 3Y29.44%
OCF growth 5Y22.55%

MANHATTAN ASSOCIATES INC / MANH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status for MANH stock?

ChartMill assigns a valuation rating of 4 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Fairly Valued.


How profitable is MANHATTAN ASSOCIATES INC (MANH) stock?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


How financially healthy is MANHATTAN ASSOCIATES INC?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.


What is the expected EPS growth for MANHATTAN ASSOCIATES INC (MANH) stock?

The Earnings per Share (EPS) of MANHATTAN ASSOCIATES INC (MANH) is expected to grow by 4.92% in the next year.